The criterion for eligibility was initially set as “articles that measured IGF peripheral members in humans with an official diagnosis of a psychiatric disorder (SZ, MDD, BD, BPD, OCD, ASD or ADHD)”. The gene discussed is IGF1; the disease is Behcet disease.